It is, however, well-known that a small proportion of patients with clear cell renal cell cancer (CCRCC) has erythrocytosis and a larger part EPO production in the cancer cells (Palapattu et al., 2002; Wiesener et al., 2007). Here, EPO is linked to nonpapillary renal cell carcinoma.